禁煙・ニコチン除去製品市場：製品別、流通別-2025-2030年の世界予測

禁煙・ニコチン除去製品市場は、2023年に282億5,000万米ドルと評価され、2024年には308億9,000万米ドルに達すると予測され、CAGR 9.65％で成長し、2030年には538億7,000万米ドルに達すると予測されています。

禁煙・ニコチン除去製品市場の範囲には、ニコチン置換療法（NRT）、非ニコチン薬、電子タバコ、ニコチンガム、パッチ、トローチ、行動療法など多様な製品が含まれます。この市場は、禁煙やニコチン依存症の軽減を目指す喫煙者をターゲットとしており、その用途は個人ユーザー、ヘルスケア施設、リハビリテーション・センターなど多岐にわたる。これらの製品の必要性は、より健康的なライフスタイルへの世界の後押し、喫煙に関連する健康被害への意識の高まり、禁煙やたばこ製品への課税強化といった政府の支持的な取り組みによって推進されています。成長に影響を与える主な要因としては、製品設計の技術的進歩、禁煙補助薬に対する意識の高まり、有利な償還政策などが挙げられます。新興経済諸国における市場プレゼンスの拡大、消費者への働きかけのためのデジタル・プラットフォームの活用、個別化禁煙プログラムのためのオーダーメイドNRTやスマートフォン用アプリケーションのような革新的製品の開発などに、最新の潜在的機会があります。しかし、市場成長は、厳しい規制環境、ジェネリック製品との競合の激しさ、禁煙ソリューションの有効性に対する消費者の懐疑的な見方といった課題に直面しています。実質的な臨床的裏付けが必要であり、高い安全基準を満たす必要があることも、市場の迅速な拡大を妨げる可能性があります。より効果的で副作用の少ない製品を生み出すために戦略的に研究開発に投資し、開発と流通のために戦略的提携を結ぶことで、制限要因に対抗することができます。技術革新が必要な分野には、現在入手可能なNRTの代替品の探索、個別化医療アプローチの開発、消費者参加と有効性追跡を向上させるための技術と科学の統合などがあります。競合考察によると、市場はポートフォリオを拡大し、未知の人口層を開拓するために、M&A活動へと大きく傾きつつあり、競争力を維持するための戦略的適応と敏捷性の必要性が浮き彫りになっています。

市場力学：急速に進化する禁煙・ニコチン除去製品市場の主要市場インサイトを公開

禁煙・ニコチン除去製品市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 呼吸器疾患や肺がんなど、喫煙による数多くの疾患の有病率の増加
  • 世界の脱中毒製品の市場浸透の拡大
  • 禁煙政策を推進する政府の好意的な取り組みと喫煙による健康への影響に対する意識向上
• 市場抑制要因
  • 技術的欠陥の増加と厳しい承認プロセスによるメーカーや企業による製品回収
• 市場機会
  • 新しいニコチン代替製品の承認と開発の増加
  • 禁煙補助製品に対する社会的・地域的支持と相まって、オンライン市場の存在感は大きい
• 市場の課題
  • 禁煙補助剤の継続使用に伴う副作用とタバコ代替品の台頭

ポーターの5つの力：禁煙・ニコチン除去製品市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：禁煙・ニコチン除去製品市場における外部からの影響の把握

外部マクロ環境要因は、禁煙・ニコチン除去製品市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析禁煙・ニコチン除去製品市場における競合情勢の把握

禁煙・ニコチン除去製品市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス禁煙・ニコチン除去製品市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、禁煙・ニコチン除去製品市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 呼吸器疾患や肺がんなど喫煙によるさまざまな疾患の増加
    • 依存症治療製品の市場浸透を世界的に拡大
    • 禁煙政策を推進し、喫煙による健康への影響に対する意識を高めるための政府の好ましい取り組み
  • 抑制要因
    • 技術的な欠陥の増加と厳格な承認プロセスにより、製造業者や企業による製品リコールが発生
  • 機会
    • 新しいニコチン代替製品の承認と開発の増加
    • 禁煙製品に対する社会的、コミュニティ的なサポートと相まって、オンライン市場で大きな存在感を示しています。
  • 課題
    • 依存症治療薬の継続使用に伴う副作用とタバコの代替品の増加
• 市場セグメンテーション分析
  • 製品：禁煙のための電子タバコの導入増加
  • 流通：利便性と秘密保持のためオンライン薬局を好む顧客傾向
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 禁煙・ニコチン除去製品市場：製品別

• 薬物療法
  • チャンティックス（バレニクリン）
  • ザイバン（ブプロピオン）
• 電子タバコ
• ニコチン吸入器
• ニコチン置換療法
  • ニコチンガム
  • ニコチントローチ
  • ニコチンスプレー
  • ニコチン経皮パッチ
• ニコチン舌下錠

第7章 禁煙・ニコチン除去製品市場配布元

• ドラッグストア
• 病院薬局
• オンライン薬局
• 小売薬局

第8章 南北アメリカの禁煙・ニコチン除去製品市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の禁煙・ニコチン除去製品市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの禁煙・ニコチン除去製品市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • BCがんセンターがプリンスジョージでニコチン置換療法のパイロットプログラムを開始
  • インペリアル・タバコ・カナダは禁煙製品の発売に興奮している
  • NCDHHSは、タバコや電子タバコをやめることをより身近にするために、新しいQuitlineNCサービスを開始しました。

企業一覧

• 22nd Century Group, Inc.
• Alkalon A/S
• Axsome Therapeutics, Inc.
• British American Tobacco PLC
• Cipla Ltd.
• Ditch Labs
• Dr. Reddy's Laboratories Limited
• Enorama Pharma AB
• GlaxoSmithKline PLC
• Glenmark Pharmaceuticals Limited
• Imperial Tobacco Company of India Limited
• Itaconix
• Japan Tobacco Inc.
• Johnson & Johnson
• JUUL Labs, Inc.
• Novartis International AG
• Perrigo Company PLC
• Pfizer Inc.
• Philip Morris International Inc.
• Pierre Fabre S.A.
• Rusan Pharma Ltd.
• Samyang Holdings Corporation
• Sparsha Pharma International Pvt. Ltd.
• Strides Pharma Science Limited

LIST OF FIGURES

• FIGURE 1. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET RESEARCH PROCESS
• FIGURE 2. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET DYNAMICS
• TABLE 7. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY CHANTIX (VARENICLINE), BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ZYBAN (BUPROPION), BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E-CIGARETTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE INHALERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE GUMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE LOZENGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SPRAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SUBLINGUAL TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG STORE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 39. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 41. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 42. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 61. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 63. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 64. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 65. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 67. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 68. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 134. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 136. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 137. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 150. POLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. POLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 152. POLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 153. POLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 154. QATAR SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. QATAR SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 156. QATAR SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 157. QATAR SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 194. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 195. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023

The Smoking Cessation & Nicotine De-Addiction Product Market was valued at USD 28.25 billion in 2023, expected to reach USD 30.89 billion in 2024, and is projected to grow at a CAGR of 9.65%, to USD 53.87 billion by 2030.

The scope of the Smoking Cessation & Nicotine De-Addiction Product market includes a diverse range of products such as nicotine replacement therapies (NRT), non-nicotine medications, e-cigarettes, nicotine gums, patches, lozenges, and behavioral therapies. This market targets smokers seeking to quit and reduce nicotine dependency, with applications spanning across individual users, healthcare facilities, and rehabilitation centers. The necessity for these products is driven by the global push toward healthier lifestyles, increasing awareness of smoking-related health hazards, and supportive government initiatives, such as smoking bans and higher taxes on tobacco products. Key influencing growth factors include technological advancements in product design, increasing awareness about smoking cessation aids, and favorable reimbursement policies. Latest potential opportunities lie in expanding market presence in emerging economies, leveraging digital platforms for consumer outreach, and developing innovative products like tailor-made NRTs and smartphone applications for personalized cessation programs. However, market growth faces challenges such as stringent regulatory environments, high competition from generic products, and possible consumer skepticism toward the efficacy of de-addiction solutions. The need for substantial clinical backing and the requirement to meet high safety standards could also hinder swift market expansion. Limiting factors can be countered by strategically investing in R&D to create more effective and less side-effect-prone products and by forming strategic alliances for development and distribution. Areas ripe for innovation include exploring alternatives to currently available NRTs, developing personalized medicine approaches, and integrating technology and science for better consumer engagement and efficacy tracking. Insightfully, the market is evolving with a significant tilt toward merger and acquisition activities, to expand portfolios and tap uncharted demographics, highlighting the need for strategic adaptation and agility to remain competitive.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Smoking Cessation & Nicotine De-Addiction Product Market

The Smoking Cessation & Nicotine De-Addiction Product Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing Prevalence of Numerous Diseases due to Smoking Such as Respiratory Disorders and Lung Cancer
  • Expanding Market Penetration of De-Addiction Products Globally
  • Favorable Government Initiatives to Promote Anti-Smoking Policy and Raising Awareness of the Health Impact due to Smoking
• Market Restraints
  • Product Recalls by the Manufacturer and Companies owing to increasing Technical Faults and Stringent Approval Process
• Market Opportunities
  • Increasing Approvals and Development of New Nicotine Replacement Products
  • Significant Online Market Presence Coupled with Social and Communal Support for Smoking Cessation Products
• Market Challenges
  • Side Effects Associated with the Continued Usage of De-Addiction Products Coupled with Rising of Alternatives to Tobacco

Porter's Five Forces: A Strategic Tool for Navigating the Smoking Cessation & Nicotine De-Addiction Product Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Smoking Cessation & Nicotine De-Addiction Product Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Smoking Cessation & Nicotine De-Addiction Product Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Smoking Cessation & Nicotine De-Addiction Product Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Smoking Cessation & Nicotine De-Addiction Product Market

A detailed market share analysis in the Smoking Cessation & Nicotine De-Addiction Product Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Smoking Cessation & Nicotine De-Addiction Product Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Smoking Cessation & Nicotine De-Addiction Product Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Smoking Cessation & Nicotine De-Addiction Product Market, highlighting leading vendors and their innovative profiles. These include 22nd Century Group, Inc., Alkalon A/S, Axsome Therapeutics, Inc., British American Tobacco PLC, Cipla Ltd., Ditch Labs, Dr. Reddy's Laboratories Limited, Enorama Pharma AB, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Imperial Tobacco Company of India Limited, Itaconix, Japan Tobacco Inc., Johnson & Johnson, JUUL Labs, Inc., Novartis International AG, Perrigo Company PLC, Pfizer Inc., Philip Morris International Inc., Pierre Fabre S.A., Rusan Pharma Ltd., Samyang Holdings Corporation, Sparsha Pharma International Pvt. Ltd., and Strides Pharma Science Limited.

Market Segmentation & Coverage

This research report categorizes the Smoking Cessation & Nicotine De-Addiction Product Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, and Nicotine Sublingual Tablets. The Drug Therapy is further studied across Chantix (Varenicline) and Zyban (Bupropion). The Nicotine Replacement Therapies is further studied across Nicotine Gums, Nicotine Lozenges, Nicotine Sprays, and Nicotine Transdermal Patches.
• Based on Distribution, market is studied across Drug Store, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing Prevalence of Numerous Diseases due to Smoking Such as Respiratory Disorders and Lung Cancer
    • 5.1.1.2. Expanding Market Penetration of De-Addiction Products Globally
    • 5.1.1.3. Favorable Government Initiatives to Promote Anti-Smoking Policy and Raising Awareness of the Health Impact due to Smoking
  • 5.1.2. Restraints
    • 5.1.2.1. Product Recalls by the Manufacturer and Companies owing to increasing Technical Faults and Stringent Approval Process
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing Approvals and Development of New Nicotine Replacement Products
    • 5.1.3.2. Significant Online Market Presence Coupled with Social and Communal Support for Smoking Cessation Products
  • 5.1.4. Challenges
    • 5.1.4.1. Side Effects Associated with the Continued Usage of De-Addiction Products Coupled with Rising of Alternatives to Tobacco
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Rising adoption of E-cigarettes for smoking cessation
  • 5.2.2. Distribution: Customer inclination towards online pharmacies for convenience and discretion
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Smoking Cessation & Nicotine De-Addiction Product Market, by Product

• 6.1. Introduction
• 6.2. Drug Therapy
  • 6.2.1. Chantix (Varenicline)
  • 6.2.2. Zyban (Bupropion)
• 6.3. E-Cigarettes
• 6.4. Nicotine Inhalers
• 6.5. Nicotine Replacement Therapies
  • 6.5.1. Nicotine Gums
  • 6.5.2. Nicotine Lozenges
  • 6.5.3. Nicotine Sprays
  • 6.5.4. Nicotine Transdermal Patches
• 6.6. Nicotine Sublingual Tablets

7. Smoking Cessation & Nicotine De-Addiction Product Market, by Distribution

• 7.1. Introduction
• 7.2. Drug Store
• 7.3. Hospital Pharmacies
• 7.4. Online Pharmacies
• 7.5. Retail Pharmacies

8. Americas Smoking Cessation & Nicotine De-Addiction Product Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Smoking Cessation & Nicotine De-Addiction Product Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Smoking Cessation & Nicotine De-Addiction Product Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. BC Cancer Launches Nicotine Replacement Therapy Pilot Program in Prince George
  • 11.3.2. Imperial Tobacco Canada Is Excited To Launch A Smoking Cessation Product
  • 11.3.3. NCDHHS Launches New QuitlineNC Services to Make Stopping Tobacco Use and Vaping More Accessible

Companies Mentioned

• 1. 22nd Century Group, Inc.
• 2. Alkalon A/S
• 3. Axsome Therapeutics, Inc.
• 4. British American Tobacco PLC
• 5. Cipla Ltd.
• 6. Ditch Labs
• 7. Dr. Reddy's Laboratories Limited
• 8. Enorama Pharma AB
• 9. GlaxoSmithKline PLC
• 10. Glenmark Pharmaceuticals Limited
• 11. Imperial Tobacco Company of India Limited
• 12. Itaconix
• 13. Japan Tobacco Inc.
• 14. Johnson & Johnson
• 15. JUUL Labs, Inc.
• 16. Novartis International AG
• 17. Perrigo Company PLC
• 18. Pfizer Inc.
• 19. Philip Morris International Inc.
• 20. Pierre Fabre S.A.
• 21. Rusan Pharma Ltd.
• 22. Samyang Holdings Corporation
• 23. Sparsha Pharma International Pvt. Ltd.
• 24. Strides Pharma Science Limited